Sandoz Private Limited Citalopram Export Data — India (DGFT 2022–2026)

Name: Sandoz Private Limited Citalopram Export Records India — #7 Exporter, 281 Shipments, $12.9M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Citalopram

India Pharmaceutical Trade Intelligence

$254.5M257 Suppliers101 CountriesHS 30049099

ExportsIndia → MOROCCO31.6%India → UNITED STATES28.8%

ImportsCANADA → India$5.3M UNITED STATES → India$24.9K

#1 Supplier: MEDISPRAY LABORATORIES #1 Buyer: CIPLA MAROC

Sandoz Private Limited — Citalopram Exporter #7 | $12.9M Trade Value | TransData Nexus | TransData Nexus

Sandoz Private Limited — Citalopram Exporter Profile

Indian Pharmaceutical Exporter · #7 for Citalopram · $12.9M export value · DGFT Verified

Sandoz Private Limited is the #7 Indian exporter of Citalopram with $12.9M in export value and 281 verified shipments. Sandoz Private Limited holds a 5.1% market share in Citalopram exports across 9 countries. The company exports 25 pharmaceutical products worth $159.4M across 15 therapeutic categories.

Sandoz Private Limited — Citalopram Export Profile: Buyers & Destinations

Sandoz Private Limited Citalopram export treemap — buyers and destination countries | TransData Nexus

Where Does Sandoz Private Limited Export Citalopram?

Country	Value	Shipments	Share
POLAND	$4.4M	143	49.4%
BRAZIL	$1.5M	36	17.0%
KOREA,REPUBLIC OF	$636.7K	17	7.1%
SLOVENIA	$478.8K	17	5.4%
REPUBLIC OF KOREA

Who Are the Top Buyers of Citalopram from Sandoz Private Limited?

Buyer	Country	Value	Orders
LEK S.A.	POLAND	$3.0M	112
LEK S A	POLAND	$1.5M	31
SANDOZ DO BRASIL IND FARMACEUTICA	BRAZIL	$802.4K	20
SANDOZ DO BRASIL IND FARMAC?UTICA	BRAZIL	$593.9K	13
SAMIL PHARMACEUTICAL CO., LTD.	REPUBLIC OF KOREA	$365.5K	8
HEXAL (SANDOZ) KOREA	KOREA,REPUBLIC OF	$359.6K	11
NOVARTIS LLC - PM - PRODUCTION MATE	SLOVENIA	$303.5K	10
SANDOZ KOREA LTD.	KOREA,REPUBLIC OF	$277.1K	6
SANDOZ CANADA INC.	CANADA	$257.6K	7
SANDOZ KOREA LIMITED	SOUTH KOREA	$248.5K	6

Sandoz Private Limited supplies Citalopram to 32 buyers globally. The largest buyer is LEK S.A. (POLAND), followed by LEK S A (POLAND) and SANDOZ DO BRASIL IND FARMACEUTICA (BRAZIL). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Citalopram Formulations Does Sandoz Private Limited Export?

Product Description / Formulation	Value	Shipments
Material No. - 42034110 ESCITALOPRAM OXA	$400.0K	8
ESCITALOPRAM OXA FCT 10MG IN91 SH EU 04	$350.0K	7
MATERIAL NO. 42034100 ESCITALOPRAMOXA FCT 20MG IN91 SH EU 05	$347.1K	18
MATERIAL NO. 42034110 ESCITALOPRAMOXA FCT 10MG IN91 SH EU 04	$223.5K	9
Material No. - 42030715, ESCITALOPRAM OX	$200.0K	4
ESCITALOPRAM OXA FCT 10MG IN91 SH EU 06MATERIAL NO 42039084	$200.0K	4
Material No. - 42034100 ESCITALOPRAM OXA	$150.0K	3
ESCITALOPRAM OXA FCT 20MG IN91 SH EU 05	$150.0K	3
ESCITALOPRAM OXA FCT 20MG IN91 SH EU 07MATERIAL NO 42039083	$150.0K	3
MATERIAL NO-42030715 ESCITALOPRAM OXA FCT 20MG IN91 SH MSPCS	$149.2K	3

Sandoz Private Limited exports 151 distinct Citalopram formulations including tablets, capsules, syrups, and combination drugs. The top formulation is Material No. - 42034110 ESCITALOPRAM OXA with 8 shipments worth $400.0K.

How Does Sandoz Private Limited Compare to Nearest Citalopram Exporters?

Exporters ranked immediately above and below #7 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
4	TORRENT PHARMACEUTICALS LTD	$17.3M	345	15	$50.0K
6	AUROBINDO PHARMA LIMITED	$13.5M	420	14	$32.0K
7	SANDOZ PRIVATE LIMITED ★	$12.9M	281	9	$46.1K
5	MYLAN LABORATORIES LIMITED	$10.1M	202	4	$50.0K
8	CIPLA LIMITED	$8.2M	239	7	$34.5K

Sandoz Private Limited ranks #7 among 257 Indian Citalopram exporters. Average shipment value of $46.1K compared to the market average of $579.1K. The closest competitors by value are TORRENT PHARMACEUTICALS LTD and AUROBINDO PHARMA LIMITED.

Which Indian Ports Ship Citalopram Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	779	10.6%
SAHAR AIR	684	9.3%
NHAVA SHEVA SEA (INNSA1)	609	8.3%
HYDERABAD ICD	593	8.0%
HYDERABAD ICD (INSNF6)	411	5.6%
HYDERABAD AIR	336	4.6%
DELHI AIR CARGO ACC (INDEL4)	334	4.5%
DELHI AIR	309	4.2%

Geopolitical & Trade Policy Impact on Sandoz Private Limited's Citalopram Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Sandoz Private Limited. The escalation of conflicts in West Asia, particularly between Israel and Iran, has disrupted vital trade corridors such as the Red Sea and the Strait of Hormuz. These disruptions have led to increased shipping costs and extended transit times, impacting the timely delivery of pharmaceutical products. The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has warned that prolonged disruptions could result in potential losses of up to ₹5,000 crore for the industry. (timesofindia.indiatimes.com)

Conversely, the ongoing US-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, creating opportunities for Indian exporters. Sandoz's established presence and compliance with international quality standards position it favorably to capitalize on this shift. However, the company must navigate the complexities of the European Union's Falsified Medicines Directive, which imposes stringent regulations to prevent counterfeit medicines from entering the supply chain. Adherence to these regulations is crucial for maintaining access to the lucrative EU market.

Sandoz Private Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Sandoz Private Limited. The company adheres to guidelines set forth by the U.S. Food and Drug Administration (FDA), the World Health Organization (WHO), and the European Union's Good Manufacturing Practices (EU GMP). Maintaining these certifications ensures the quality and safety of its products, facilitating access to global markets.

The evolving regulatory environment necessitates continuous investment in quality assurance and compliance. Sandoz's commitment to these standards not only mitigates the risk of regulatory actions but also enhances its reputation as a reliable supplier in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Citalopram shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Sandoz Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 281 individual customs records matching Sandoz Private Limited exporting Citalopram, covering 151 formulations to 12 countries via 32 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 101+ countries, 736+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Citalopram

Citalopram

Sandoz Private Limited — Citalopram Exporter Profile

Sandoz Private Limited — Citalopram Export Profile: Buyers & Destinations

Where Does Sandoz Private Limited Export Citalopram?

Who Are the Top Buyers of Citalopram from Sandoz Private Limited?

What Is India's Total Citalopram Export Value and How Much Does Sandoz Private Limited Contribute?

What Is the Average Shipment Value for Sandoz Private Limited's Citalopram Exports?

How Does Sandoz Private Limited Compare to Other Indian Citalopram Exporters?

What Citalopram Formulations Does Sandoz Private Limited Export?

Regulatory Requirements: Exporting Citalopram to Key Markets

Brazil — ANVISA

How Does Sandoz Private Limited Compare to Nearest Citalopram Exporters?

Which Indian Ports Ship Citalopram Exports?

What Other CNS & Psychiatric Products Does Sandoz Private Limited Export?

Geopolitical & Trade Policy Impact on Sandoz Private Limited's Citalopram Exports

Sandoz Private Limited — Regulatory Compliance & Quality Standards

About Sandoz Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Citalopram Export Data from Sandoz Private Limited

Citalopram Stats

Company Overview

Top Products by Sandoz Private Limited

Related Analysis

Need Detailed Export Data?

Data Source